Yoshiyama Annie
SVP, Finance
Yoshiyama Annie has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 23, 2026.
On the most recent filing, Yoshiyama Annie is listed as SVP, Finance at Allogene Therapeutics, Inc. Inside the rolling window, Yoshiyama Annie reported no open-market purchases and 2 open-market sales totaling $29K in ALLO. The largest disclosed transaction in the window is a sale of 9,586 ALLO shares on Apr 21, 2026, worth $22K.
Companies traded
Other insiders at ALLO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$29K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Yoshiyama Annie made?
Yoshiyama Annie has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2026.
Which companies does Yoshiyama Annie trade?
Yoshiyama Annie has filed SEC Form 4 disclosures for 1 company, including ALLO.
When was Yoshiyama Annie's most recent SEC Form 4 filing?
Yoshiyama Annie's most recent SEC Form 4 filing on Tracefour is dated Apr 23, 2026.
What is Yoshiyama Annie's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Yoshiyama Annie is listed as SVP, Finance.
What is Yoshiyama Annie's total buy and sell value in the current window?
Inside the rolling retention window, Yoshiyama Annie bought $0 and sold $29K based on SEC Form 4 filings.
What was Yoshiyama Annie's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 9,586 ALLO shares on 2026-04-21, worth $22K, per SEC Form 4 filings.